Supplementary Data 1 from Health-Related Quality of Life Impact from Adding Bevacizumab to Cisplatin-Pemetrexed in Malignant Pleural Mesothelioma in the MAPS IFCT-GFPC-0701 Phase III TrialGuillaume Eberst,Amélie Anota,Arnaud Scherpereel,Julien Mazieres,Jacques Margery,Laurent Greillier,Clarisse Audigier-Valette,Denis Moro-Sibilot,Olivier Molinier,Hervé Léna,Frédéric Rivière,Isabelle Monnet,Valérie Gounant,Henri Janicot,Radj Gervais,Chrystelle Locher,Emilie Charton,Franck Morin,Gérard Zalcman,Virginie Westeelcrossref（2023）引用 0|浏览3AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
